Home/Filings/4/A/0001209191-23-008134
4/A//SEC Filing

Hinrichs James F. 4/A

Accession 0001209191-23-008134

CIK 0000884624other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 6:03 PM ET

Size

5.3 KB

Accession

0001209191-23-008134

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-05
Transactions
  • Award

    Common Stock

    2023-01-05+14,35477,859 total
Footnotes (3)
  • [F1]Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.
  • [F2]This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.
  • [F3]Includes 39,548 deferred stock units.

Issuer

Orthofix Medical Inc.

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001506974

Filing Metadata

Form type
4/A
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:03 PM ET
Size
5.3 KB